SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-009845
Filing Date
2020-04-27
Accepted
2020-04-27 17:18:09
Documents
6
Period of Report
2020-06-11
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 645237
2 image0.jpg GRAPHIC 90213
3 image1.jpg GRAPHIC 59011
4 image2.jpg GRAPHIC 123703
5 proxycard01.jpg GRAPHIC 261053
6 proxycard02.jpg GRAPHIC 174486
  Complete submission text file 0001140361-20-009845.txt   1622254
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 20821208
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences